Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixazomib for cGVHD Prophylaxis
NCT03225417Phase 2Active, not recruiting
- Sponsor
- Fundación Pública Andaluza para la Gestión de la Investigación
- Start
- May 2017
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixazomib in chronic graft-versus-host disease (cGVHD), sponsored by Fundación Pública Andaluza para la Gestión de la Investigación. Started May 2017; status: active, not recruiting.
02
Drugs
ixazomib
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT03225417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03225417.